Podbregar Matej

7PUBLICATIONS
12CO-AUTHORS
Respiratory diseasesMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 03, 2026
Individualized target heart rate in critically ill atrial fibrillation patients: insights from echocardiography and physiological signal analysis.

|Apr 23, 2025
Fulminant Red Yeast Rice-Associated Rhabdomyolysis with Acute Liver Injury and Hyperkalemia Treated with Extracorporeal Blood Purification Using CytoSorb.

Marko Kurnik, Tilen Markelj, Borut Žgavc

|Nov 16, 2024
Fatal rhabdomyolysis and fulminant myocarditis with malignant arrhythmias after one dose of ipilimumab and nivolumab.

Marko Kurnik, Petra Kolar Kus, Mihela Krepek

|Oct 26, 2024
Functional Magnetic Neuromuscular Stimulation vs. Routine Physiotherapy in the Critically Ill for Prevention of ICU Acquired Muscle Loss: A Randomised Controlled Trial.

Anej Skočir, Alja Jevšnik, Lidija Plaskan

|Jul 17, 2024
Tocilizumab and CytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapy.

Marko Kurnik, Fazarinc Peter, Podbregar Matej

|Jan 18, 2023
Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study.

Marko Kurnik, Helena Božič, Anže Vindišar

Pageof 2

Frequent Collaborators

3 joint publications

Marko Kurnik

1 joint publications

Jan Benes

1 joint publications

Miłosz Jankowski

1 joint publications

Konstanty Szułdrzynski